ONCT - Oncternal Therapeutics reports Q3 results November, 07 2019 04:30 PM Oncternal Therapeutics Inc. Oncternal Therapeutics (NASDAQ:ONCT): Q3 GAAP EPS of -$0.32.Revenue of $0.54M (+63.6% Y/Y)Press ReleaseMore news on: Oncternal Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,